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Transient ischaemic attack (TIA) and minor stroke are characterized by short-lasting symptoms; 
however, anecdotal and empirical evidence suggests that these patients experience ongoing 
cognitive/psychological impairment for which they are not routinely treated. The aims were (i) to 
investigate the prevalence and time course of fatigue, anxiety, depression, post-traumatic stress 
disorder(PTSD) and cognitive impairment following TIA/minor stroke; (ii) to explore the impact on 
quality of life (QoL), change in emotions and return to work; and (iii) to identify where further 
research is required and potentially inform an intervention study. A systematic review of MEDLINE, 
EMBASE, PSYCINFO, CINAHL, the Cochrane libraries and the grey literature between January 1993 
and April 2013 was undertaken. Literature was screened and data were extracted by two 
independent reviewers. Studies were included of adult TIA/minor stroke participants with any of the 
outcomes of interest: fatigue, anxiety, depression, PTSD, cognitive impairment, QoL, change in 
emotions and return to work. Random-effects meta-analysis pooled outcomes by measurement 
tool. Searches identified 5976 records, 289 were assessed for eligibility and 31 studies were 
included. Results suggest high levels of cognitive impairment and depression post-TIA/minor stroke 
which decreased over time. However, frequencies varied between studies. Limited information was 
available on anxiety, PTSD and fatigue. Meta-analysis revealed that the measurement tool 
administered influenced the prevalence of cognitive impairment: Mini-Mental State Examination 
17% [95% confidence interval (CI) 7, 26]; neuropsychological test battery 39% (95% CI 28, 50); 
Montreal Cognitive Assessment 54% (95% CI 43, 66). There is evidence to suggest that TIA/minor 
stroke patients may experience residual impairments; however, results should be interpreted with 
caution because of the few high quality studies. Notwithstanding, it is important to raise awareness 
of potential subtle but meaningful residual impairments. 
Introduction 
Transient ischaemic attack (TIA) and minor stroke are characterized by short-lasting symptoms [1,2]. 
These patients are discharged rapidly from hospital and treatment guidelines focus on secondary 
prevention of stroke [3]. However, there is evidence to suggest that TIA and minor stroke patients 
may experience residual impairments for which they are not routinely offered treatment. Coutts et 
al. [4] reported 15% of a sample of TIA and minor stroke participants (n = 499) were disabled at 90 
days as defined by a modified Rankin Scale score ≥2. In addition, Fens et al. [5] found that 
approximately half of a sample of TIA and minor stroke participants (n = 55) self-reported cognitive 
and communication difficulties, which was significantly higher (P ≤ 0.001) than angina controls (n = 
72). Anecdotal evidence from patient interviews revealed that TIA and minor stroke patients 
experienced a variety of ongoing residual symptoms including memory and speech difficulties; 
feeling confused and more emotional; mild limb weakness and numbness [6]. Subtle but meaningful 
impairment post-TIA and minor stroke may go undetected. If untreated, these impairments may 
result in a reduced quality of life (QoL), affect people’s ability to return to work and social activities 
and may affect behaviour related to future stroke prevention. Fatigue, psychological and cognitive 
impairments occur post-stroke and are potential sequelae of TIA and minor stroke; therefore, there 
is a need for a comprehensive systematic review of the literature to investigate these impairments 
post-TIA/minor stroke.  
The aims of this systematic review were (i) to establish the prevalence of fatigue, anxiety, 
depression, post-traumatic stress disorder (PTSD) and cognitive impairment following TIA and minor 
stroke and to investigate the temporal course of these impairments; (ii) to explore the impact on 
QoL, change in emotions and return to work; (iii) to identify where further research is required and 
to potentially inform an intervention study, e.g. a cognitive rehabilitation intervention study, if 
impaired cognition was observed. 
Methods 
The full protocol for this systematic review was published as ‘A systematic review investigating 
fatigue, psychological and cognitive impairment following TIA and minor stroke: protocol paper’ [7]. 
The methods are summarized in brief below. 
Eligibility criteria 
Studies that reported the frequency of fatigue, anxiety, depression, PTSD or cognitive impairment, 
measured by validated tests, after TIA or minor stroke were identified. Studies reporting QoL, 
change in emotions and return to or performance at work were also included. Studies of mixed 
populations whereby it was possible to extract TIA or minor stroke data were included. Studies were 
excluded if they reported participants who had a history of stroke or a stroke during follow-up. All 
study designs were eligible with the exception of single case series and reviews. If possible, data 
were extracted from a control group if participants were free of stroke, TIA and minor stroke. There 
was no limit to the duration of follow-up. Full journal articles, conference abstracts and theses were 
included. Non-English papers were eligible and were screened for inclusion by research-active 
translators; however, none met the inclusion criteria. 
Search strategy and data extraction 
The following electronic databases were searched: MEDLINE, EMBASE, PSYCINFO, CINAHL, DARE, 
CENTRAL and CDSR. For pragmatic and quality of reporting reasons the search was limited to 20 
years; therefore, databases were searched from January 1993 to April 2013. Grey literature was 
searched including Google Scholar, ProQuest Dissertation Theses Database, thesis.com and 
Conference Proceedings Citation Index. References from included studies were also checked. A 
comprehensive search strategy was developed through scoping searches and comprised the 
following elements: TIA, minor stroke, fatigue, anxiety, depression, PTSD and cognitive impairment 
(Appendix S1). 
Two authors (GM and BF) independently screened titles and abstracts of search results; assessed the 
full text of relevant studies for eligibility; and completed data extraction and risk of bias assessments 
for included studies. Information was extracted on study characteristics, participants, controls and 
outcomes. The risk of bias assessment focused on sampling, measurement of outcomes, attrition 
and analysis. This assessment did not generate an overall risk of bias score but a judgement of ‘yes’, 
‘no’ or ‘unclear’, as recommended by Cochrane (Fig. S1). 
Analysis 
To explore the time course of outcomes, studies were grouped into short term (<3 months after 
TIA/minor stroke), medium term (3–12 months) and long term (over 12 months). Due to the 
heterogeneity of the measurement tools, it was not appropriate to pool frequencies at these time 
points as pre-specified. It was deemed appropriate to pool outcomes by measurement tool; 
therefore, a random-effects meta-analysis pooled studies which used the same measurement tool. 
For studies measuring outcomes at more than one time point, the protocol planned exploratory 
analysis of new cases compared with persistent cases to investigate the natural history of the 
outcomes. However, this information was only reported by one study. Anecdotal evidence suggests 
that TIA and minor stroke patients experience residual memory and attention impairments; 
therefore, an analysis to investigate these specific domains was planned in the protocol. However, 
not enough studies were included that reported these data to conduct this sub-analysis. Chi-squared 
and Fisher’s exact tests were used to detect a statistically significant difference in a sub-analysis of 
studies with a suitable control group and to compare TIA and minor stroke frequencies. All statistical 
analysis was performed using STATA v12 (College Station, TX, USA). A narrative synthesis of results 
was also conducted.  
Results 
Electronic database searches identified 5976 records; 4237 remained after duplicate removal; 3954 
were excluded on the basis of their titles leaving 289 to be assessed for eligibility and 31 met the 
inclusion criteria and were subsequently included (Fig. 1).  
 
Figure 1 Summary of study selection. 
Study characteristics 
The 31 studies included 4109 participants and comprised 26 full text publications, three conference 
abstracts and two unpublished theses. Study designs were either case series (n = 25) or cohort 
studies (n = 6). Studies were located in Europe, North America and Asia. The majority (n = 22) 
recruited from a secondary care setting and 11 out of 15 studies that reported recruitment methods 
used consecutive recruitment. 
Risk of bias 
Assessment of the risk of bias revealed that the sampling domain was the weakest; only 10% of 
studies reported how the sample size was determined and consequently it was unclear if sample 
sizes were adequate. Furthermore, the presence of any of the outcomes before TIA or minor stroke 
was measured in under half the studies. The measurement, attrition and analysis domains were 
generally reported well (Fig. S1). 
Prevalence of cognitive impairment 
Cognitive impairment was measured in 15 studies [8–22]; 13 reported overall cognitive impairment 
(Table 1) and five impairment of specific cognitive domains (Table S1). A wide variation in prevalence 
of cognitive impairment was observed between studies and there was marked variation in 
frequencies assessed by different measurement tools. The meta-analysis pooled studies by 
measurement tool: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) 
and neuropsychological test battery when overall cognitive impairment was reported rather than 
individual tests. The pooled point estimate of the prevalence of cognitive impairment was lowest as 
estimated by the MMSE at 17% [95% confidence interval (CI) 7, 26] followed by the 
neuropsychological test battery at 39% (95% CI 28, 50) and MoCA at 54% (95% CI 43, 66) (Fig. 2a). 
The higher prevalence of cognitive impairment when assessed by MoCA compared with MMSE was 
confirmed in the two studies that directly compared these tools and observed a significant 
difference (P≤0.001) [9,17]. 
An overall decrease in frequency of cognitive impairment with time was observed across studies; 
however, at individual time points there was variation in frequencies between studies (Fig. 3). In 
contrast to the overall trend, the two studies that measured cognitive impairment at two time 
points found no significant difference in prevalence [18,20]. MoCA produced a greater difference in 
prevalence of cognitive impairment than MMSE when comparing TIA and minor stroke participants 
to controls, which was significant in two studies (P≤0.01) [12,22]. Significantly higher frequencies of 
cognitive impairment (P≤0.05) were observed in minor stroke participants compared with TIA 
participants [8,9,18]. 
Prevalence of depression 
Depression was reported in 10 studies (Table 2) [8,10,23–30]. Prevalence of depression was high 
within 1 month of TIA or minor stroke and decreased between 6 weeks and 3 months. With the 
exception of one study [10], the prevalence of depression remained relatively low between 3 and 12 
months (Fig. 2b). No significant difference in the prevalence of depression was observed between 
TIA or minor stroke participants and controls in the two studies that measured this [8,24]. Likewise, 
one study reported prevalence of depression separately for TIA and minor stroke participants and 
found no significant difference between these participants [24]. 
 
Table 1 Studies measuring cognitive impairment: summary of measurement tool, participants’ diagnosis, time point of assessment, 
sample size and frequencies 
 
 
 
Prevalence of fatigue 
Three studies measured fatigue, all between 6 and 12 months following TIA or minor stroke; 
however, each study administered a different fatigue questionnaire (Table 3) [20,31,32]. Prevalence 
estimates were similar for all studies (Fig. 2c). One study found no significant difference in 
prevalence of fatigue (P = 0.741) measured at 6 and 12 months [20]. This was the only study to 
investigate the natural history of fatigue and found that two-thirds of the participants who reported 
fatigue at 6 months remained fatigued at 12 months. One study found that minor stroke participants 
reported a significantly higher prevalence of fatigue compared with TIA participants (P = 0.008) [32]. 
Prevalence of anxiety 
Two studies measured anxiety. One observed anxiety frequencies of 52% and 65% for TIA and minor 
stroke participants respectively at 14 days; these frequencies were significantly different (P ≤ 0.005) 
compared with controls (23%) [24]. The other study found a prevalence of anxiety in 24% of minor 
stroke participants at 12 months [25]. Both these studies administered the anxiety questions of the 
Hospital Anxiety and Depression Scale (HADS-A); however, two different cut-off scores of >4 [24] 
and >8 [25] were used to define anxiety. 
 
 
 
 
 
Figure 2 Prevalence of cognitive impairment, depression and fatigue after transient ischaemic attack (TIA) and minor stroke: (a) 
random-effects meta-analysis pooled estimates for the proportion of cognitive impairment as assessed by Mini-Mental State 
Examination (MMSE), Montreal Cognitive Assessment (MoCA) and neuropsychological test battery; (b) proportion of 
depression; (c) proportion of fatigue. 
 
 
Figure 3 Time course of cognitive impairment after transient ischaemic attack (TIA) or minor stroke as measured by the 
Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) and neuropsychological test battery. 
 
Prevalence of PTSD 
Only one study reported PTSD, finding a prevalence of 31% at 12 months after minor stroke [25]. 
This study used the Impact of Events Scale with a cut-off score of 30 and had a small sample size (n = 
49).  
Secondary outcomes  
Quality of life (QoL) was measured by six studies and there was considerable variation in the 
measurement tools administered and how the results were reported (Table S2) [33–38]. Muss et al. 
[38] reported that 43% of TIA and minor stroke participants had a worse QoL at 12 months 
compared with pre-stroke QoL. Return to work was reported in three studies between 6 and 12 
months post-minor stroke. The definition of return to work varied between the studies but high 
frequencies of non-return, between 55% and 66%, were observed [10,20,33]. Two studies reported 
change in emotions following minor stroke; emotional lability was found in 38% of participants at 12 
months [10] and irritable mood in 22% of participants at 6 months [33]. 
Table 2 Studies measuring depression: summary of measurement tool, participants’ diagnosis, time point of assessment, sample size 
and frequencies 
 
 
 
Table 3 Studies measuring fatigue: summary of measurement tool, participants’ diagnosis, time point of assessment, sample size and 
frequencies 
 
Discussion 
This comprehensive systematic review explored the prevalence of fatigue, psychological and 
cognitive impairment after TIA and minor stroke. The findings provided evidence of residual 
impairments in this patient group which supports other studies that reported ongoing impairment 
post-TIA/minor stroke [4,5]. Both cognitive impairment and depression have relatively high 
prevalence following TIA and minor stroke which decreases over time. However, the findings are 
limited as few high quality studies are currently available, the reported prevalence was variable and 
the studies varied in methodology and case mix.  
Frequency of cognitive impairment following TIA and minor stroke was influenced by the 
measurement tool used. This could be expected as a neuropsychological test battery is considered 
the gold standard but MMSE and MoCA were developed as cognitive screening tools for dementia 
[39] and mild cognitive impairment [40] respectively. Low levels of cognitive impairment were 
observed when assessed with MMSE and high levels with MoCA. This suggests that TIA and minor 
stroke patients may experience mild cognitive impairment, rather than dementia, which was not 
detected by MMSE. Indeed, MMSE has been shown to be insensitive to mild cognitive impairment in 
stroke patients [41], no better than chance in detecting cognitive impairment [42] and has an 
apparent ceiling effect [43]. Therefore, MMSE may not be a suitable screening tool for TIA and minor 
stroke patients. In addition, the cognitive profile of vascular cognitive impairment, which would be 
expected following stroke, shows prominent attentional and executive deficits [44]. MoCA detects 
more deficits in these domains compared with MMSE [45]. Therefore, frequency estimates of 
cognitive impairment as assessed by MMSE may be unreliable. 
 
Across all studies, a relatively high level of cognitive impairment post-TIA and minor stroke was 
observed which decreased over time. However, cohort studies with two time points did not support 
this trend. A non-significant decrease in frequency of cognitive impairment was observed by 
Pendlebury et al.[18] and Radman et al.[20] between <1 and 1–4 weeks and 6 and 12 months 
respectively. Likewise, stroke studies have reported cognitive impairment to remain constant over 3 
[46] and 14 years [47]. Our systematic review found frequencies of cognitive impairment were 
variable at the same time point even for studies using the same measurement tool. This is probably 
caused by the heterogeneity between studies. A systematic review of post-stroke dementia found 
93% of the variance in dementia rates to be explained by study design and inclusion criteria [48]. 
It is important to determine if cognitive impairment observed in TIA and minor stroke patients is 
greater than age-related cognitive decline. The three MoCA studies with a control group showed a 
significant or near significant difference in cognitive impairment between TIA or minor stroke 
participants and controls [12,17,22]. However, when MMSE was used a non-significant difference 
was observed [17,21]. Given the previous discussion, it could be speculated that TIA and minor 
stroke patients experience mild cognitive impairment which is not detected by MMSE. However, 
these results should be interpreted with caution: only two control groups were age and sex matched 
and one used a memory clinic cohort as a control group which was obtained from a different study 
to the TIA participants. Also, none of the studies detailed if assessors were blinded to the 
participants’ diagnosis which may introduce bias. 
Depression appeared to be relatively high in the acute stage after TIA and minor stroke followed by 
an overall decrease in frequency over time across all studies. This trend is supported by Verbraak et 
al. [49] who reported that frequency of depression in TIA and minor stroke participants at 1 month 
had halved by 6 months; however, a fifth of this sample had a history of stroke. In contrast, the one 
study in our review to measure depression at two time points found no difference in prevalence 
[26]. A non-significant difference was also observed between prevalence of depression in TIA or 
minor stroke participants and controls in two studies [8,24]. Again, our findings should be 
interpreted with caution. The influence of confounding variables must be considered. For instance, 
only two studies excluded people with a history of depression. Furthermore, the average age across 
studies varied between 51 and 72 years, half of the studies had over 60% male participants and 
there were seven different measurement tools administered across the studies. Limited information 
was available for anxiety and PTSD and further research is required to provide reliable estimates of 
the prevalence of these outcomes after TIA and minor stroke. 
Prevalence of fatigue post-TIA and minor stroke was measured by three studies between 6 and 12 
months. Fatigue prevalence appears to be consistent within this time period following TIA and minor 
stroke. One study measured fatigue at an individual level and found two-thirds of participants with 
fatigue at 6 months remained fatigued at 12 months. Constant fatigue status over time (either 
fatigued or not fatigued) was observed in 72% [50] and 83% [51] of stroke participants in 
longitudinal stroke studies. This supports the trend that fatigue is stable at an individual level. None 
of the fatigue studies included in our review had a comparator group. Fatigue has been found in the 
elderly in the absence of physical or psychological explanation and is more prominent in females 
[52]. Therefore, age and sex matched controls are required to differentiate TIA or minor stroke 
induced fatigue. 
Despite being important patient-centred outcomes, there were few studies available that measured 
return to work and emotionalism post-minor stroke and none post-TIA. In addition, the information 
on QoL for this patient group could not be meaningfully interpreted without a comparator group.  
The main strength of this review is that it was designed and conducted according to Cochrane [53] 
and the Centre for Reviews and Dissemination (CDR) guidelines [54]. Furthermore, it is free of 
language bias and, to reduce publication bias, conference abstracts and theses of unpublished 
studies were included and grey literature was searched. Two reviewers worked independently to 
reduce human error and increase reliability. A limitation of the review is that authors of included 
studies were not contacted to obtain missing information. At an individual study level there were 
many limitations which impacted on the reliability and generalizability of the results. Studies were 
heterogeneous in methodology and case mix and there were a small number of studies for some of 
the outcomes. An important consideration is the lack of comparator group for most studies. 
Consequently, it was not possible to determine if prevalence of the outcomes in TIA or minor stroke 
patients is higher than prevalence for age and sex stratified subjects in the general population. In 
addition, the prevalence of the outcomes pre-TIA or minor stroke was unknown for most of the 
included studies. 
Conclusion 
The findings of this systematic review are relevant to primary healthcare professionals as TIA and 
minor stroke patients are discharged rapidly from hospital. Although the results are inconclusive, it is 
important to raise awareness of the potential subtle but meaningful residual impairments following 
TIA and minor stroke. These can be missed in patients who appear to have functionally recovered 
but may struggle with more complex activities affecting daily activities and social, work and family 
responsibilities. 
Our results are most relevant to inform future research. Future research should comprise a cohort 
study with age and sex matched controls. Studies must adjust for confounding variables and 
measure or estimate the presence of the outcome(s) pre-TIA or minor stroke to produce reliable 
results. In addition, choice of measurement tool should be carefully considered in the context of the 
population. It is reasonable to advise that a neuropsychological test battery should be used to 
measure cognitive impairment in TIA and minor stroke patients and, when this is not feasible, MoCA 
is preferred over MMSE. Future studies should investigate the natural history of outcomes as well as 
the time course.  
Overall, the results of this systematic review are limited as the evidence in the literature is weak. 
There is some evidence to suggest that TIA and minor stroke patients may experience residual 
impairments which appear to reduce in prevalence over time, but these findings should be 
interpreted with caution. Notwithstanding, this review is valuable to provide a platform to generate 
hypotheses and inform future trial design in the context of the limitations in the available literature. 
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